Advanced searches left 3/3
Search only database of 8 mil and more summaries

Israel Coronavirus Vaccination

Summarized by PlexPage
Last Updated: 02 July 2021

* If you want to update the article please login/register

General | Latest Info

Researchers have reported hopeful results from an early clinical trial of potential coronavirus Vaccine developed by a team from from Beth Israel Deaconess Medical Center and Johnson & Johnson. The company announced earlier this week it has moved forward to field testing what could be the first single - shot vaccine for viruses in the third and final Phase clinical trial. Completion of early Phase clinical trial suggests the vaccine is safe and may provide protection against COVID - 19, according to researchers. The Early Phase trial involves two groups of roughly 400 people each and was designed to test safety and probe the vaccine's potential. Researchers publish results online on Friday. While work has not yet been peer - review, Boston University immunologist Dr. Chris Gill, who does not work on vaccine says trial provide evidence the vaccine is safe but that further work is needed to show if one dose will be sufficient. Do not set off alarm bells for me, Gill say. I can SEE why they are claiming a single dose is enough, but I think they are getting ahead of their skis bit. These data give no insight if responses will wane quickly over time. If they do, one would usually need a second dose to boost. They may be right, but I don't feel they have proven their argument yet. Gill says early results are promising and enough to warrant advancement to the third phase of clinical trials. Johnson & Johnson will recruit 60 000 participants to take part in the new trial, making it the largest clinical trial of coronavirus Vaccine to date. If a vaccine is shown to be effective with simply one dose, Dr. Daniel Barouch, immunologist at Beth Israel and Harvard Medical School who led much of early research on vaccine,s says it will have an advantage over some other vaccines currently in development. Those from Moderna and Pfizer will be split into two injections roughly a month apart. Having just one shot would clear logistical hurdles in distribution, Barouch say. If a single - shot vaccine is safe and effective, then we think that would facilitate mass vaccination campaigns, he say. Barouch says Johnson & Johnson Vaccines ALSO do not need to be frozen and can remain stable at refrigerated temperatures for up to three months. Other vaccines currently in late stage clinical trials must remain frozen and will depend on dwindling supply of dry ice for shipping and transportation. It will be easier to transport to distribution sites, to hospitals, to clinics, to pharmacies, to doctors ' offices, which we think is an added advantage, Barouch say. Vaccine is based on technology that Barouch helped pioneer. It uses a disabled virus called adenovirus 26 to deliver modified genetic code for coronaviruss distinctive spike protein, feature virus used to infect cells. The body's immune system then, hopefully, recognizes spike protein and builds defenses against it.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Breakthrough on COVID-19 Vaccine

As research labs across the world rush to develop vaccines against coronavirus, World Health Organization has Pandemic potential and Israel Research Institute has claimed a breakthrough, according to Israeli website Grapevine, which focuses on Innovation in Israel. Grapevine reported that MIGAL Research Institute, based in northern Israel, held a press conference on Thursday to reveal that they have developed a coronavirus vaccine. The Findings are culmination of a four - year multi - disciplinary Research Fund by Israel Ministry of Science and Technology in cooperation with Israel Ministry of Agriculture. Migal has achieved a scientific breakthrough that will lead to rapid creation of a vaccine against coronavirus, it claim. This possibility was identified as a by - product of MIGALs development of a vaccine against IBV, disease affecting poultry, whose effectiveness has been proven in pre - clinical trials carried out at the Veterinary Institute. Migal has now made required genetic adjustments to adapt the vaccine to COVID - 19, human strain of coronavirus, and is working to achieve safety approvals that will enable in - vivo testing, enable initiation of production of vaccine to counter the coronavirus epidemic currently spreading throughout the world, which so far has claimed 2 666 lives.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

CDC reverses controversial testing guidance

The Centers for Disease Control and Prevention reversed controversial Coronavirus testing guidance that says people who were exposed to an infected person but weren't showing any symptoms do not necessarily need a test. New guidance says that people without symptoms who have been in close contact with an infected person need test. Many Public Health specialists criticize the CDC's change in testing guidance in August for appearing to downplay the significance of testing people who don't have symptoms but who might be spreading the virus. Old CDC guidance, New York Times reported earlier this week, was posted to CDC's website in August despite objections from scientists within the agency. The Reversal come amid heightened concerns of political intervention by the White House inside nation's premier health agencies, including the CDC and Food and Drug Administration.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Sources

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo

© All rights reserved
2021 made by Algoritmi Vision Inc.

If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.